CAS 864845-15-8
:4-Bromo-1,2-dihydro-3H-indazol-3-one
Description:
4-Bromo-1,2-dihydro-3H-indazol-3-one is a chemical compound characterized by its indazole core, which features a bromine substituent at the 4-position and a carbonyl group at the 3-position. This compound typically appears as a solid at room temperature and is soluble in organic solvents, reflecting its relatively non-polar nature due to the presence of the aromatic indazole structure. The bromine atom introduces both steric and electronic effects, which can influence its reactivity and interactions in chemical reactions. The presence of the carbonyl group contributes to its potential as a reactive electrophile, making it useful in various synthetic applications, including medicinal chemistry. Additionally, compounds of this type may exhibit biological activity, making them of interest in drug discovery and development. Safety data should be consulted for handling, as halogenated compounds can pose health risks. Overall, 4-Bromo-1,2-dihydro-3H-indazol-3-one is a versatile compound with applications in research and industry.
Formula:C7H5BrN2O
InChI:InChI=1S/C7H5BrN2O/c8-4-2-1-3-5-6(4)7(11)10-9-5/h1-3H,(H2,9,10,11)
InChI key:AOSWBTIWUXRHRT-UHFFFAOYSA-N
SMILES:c1cc(c2c(c1)[nH]nc2O)Br
Synonyms:- 3H-Indazol-3-one, 4-bromo-1,2-dihydro-
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
4-Bromo-1,2-dihydro-3H-indazol-3-one
CAS:4-Bromo-1,2-dihydro-3H-indazol-3-oneFormula:C7H5BrN2OPurity:98%Molecular weight:213.03144-Bromo-1H-indazol-3(2H)-one
CAS:Formula:C7H5BrN2OPurity:97%Color and Shape:SolidMolecular weight:213.03144-Bromo-1H-indazol-3(2H)-one
CAS:4-Bromo-1H-indazol-3(2H)-oneFormula:C7H5BrN2OPurity:98%Molecular weight:213.034-Bromo-1H-indazol-3(2H)-one
CAS:Formula:C7H5BrN2OPurity:97%Color and Shape:SolidMolecular weight:213.0344-bromo-1h-indazol-3(2h)-one
CAS:Remogliflozin is a potent inhibitor of the activity of the enzyme sglt2, which is involved in the regulation of glucose and lipid metabolism. Remogliflozin etabonate is an orally active metabolite that has been shown to inhibit sglt2 in mice with high oral bioavailability. This metabolite can be used as a lead compound for the discovery of novel drugs for diabetes and obesity treatment.Formula:C7H5BrN2OPurity:Min. 95%Molecular weight:213.03 g/mol
